Benoît Lechartier
Impact in
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology
- Molecular Medicine top 10%
Papers in
-
- Pulmonary Hypertension Research and Treatments 15
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 3
- Chronic Obstructive Pulmonary Disease (COPD) Research 3
-
- Tuberculosis Research and Epidemiology 8
- Co-authors
- Stewart T. Cole (7 shared papers)Ruben C. Hartkoorn (3 shared papers)Jan Rybniker (2 shared papers)Alimuddin Zumla (1 shared paper)Ming Zhang (2 shared papers)João Neres (2 shared papers)Anthony Vocat (2 shared papers)Nicolas Widmer (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (4 papers)Journal of Clinical Medicine (3 papers)ERJ Open Research (3 papers)EMBO Molecular Medicine (2 papers)CHEST Journal (2 papers)
- Partner nations
- SwitzerlandFranceUnited Kingdom
In The Last Decade
Benoît Lechartier
21 papers receiving 859 citations
Peers
Comparison fields: 5 of 71
- Infectious Diseases 540
- Molecular Medicine 67
- Epidemiology 280
- Molecular Biology 504
- Organic Chemistry 156
Countries citing papers authored by Benoît Lechartier
This map shows the geographic impact of Benoît Lechartier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benoît Lechartier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benoît Lechartier more than expected).
Fields of papers citing papers by Benoît Lechartier
This network shows the impact of papers produced by Benoît Lechartier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benoît Lechartier. The network helps show where Benoît Lechartier may publish in the future.
Co-authors
The 25 scholars most cited alongside Benoît Lechartier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 312 | |
| 2 | 2014 | 128 | |
| 3 | 2015 | 113 | |
| 4 | 2012 | 110 | |
| 5 | 2021 | 48 | |
| 6 | 2016 | 40 | |
| 7 | 2013 | 29 | |
| 8 | 2015 | 29 | |
| 9 | 2021 | 13 | |
| 10 | 2024 | 10 | |
| 11 | 2022 | 9 | |
| 12 | 2021 | 8 | |
| 13 | 2023 | 7 | |
| 14 | 2023 | 3 | |
| 15 | 2023 | 3 | |
| 16 | 2024 | 2 | |
| 17 | 2023 | 2 | |
| 18 | 2024 | 1 | |
| 19 | 2022 | 1 | |
| 20 | 2023 | 1 |
About Benoît Lechartier
Benoît Lechartier is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases, Molecular Biology, Cardiology and Cardiovascular Medicine and Epidemiology, having authored 27 papers that have together received 870 indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (15 papers), Tuberculosis Research and Epidemiology (8 papers), Cardiovascular Function and Risk Factors (4 papers), Mycobacterium research and diagnosis (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Cancer therapeutics and mechanisms (3 papers), Phenothiazines and Benzothiazines Synthesis and Activities (3 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). The work is most often cited by research in Infectious Diseases (540 citations), Molecular Medicine (67 citations), Epidemiology (280 citations), Molecular Biology (504 citations) and Organic Chemistry (156 citations). Benoît Lechartier has collaborated with scholars based in Switzerland, France and United Kingdom. Frequent co-authors include Stewart T. Cole, Ruben C. Hartkoorn, Jan Rybniker, Alimuddin Zumla, Ming Zhang, João Neres, Anthony Vocat, Nicolas Widmer, Koen Andries and O. B. Ryabova. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Clinical Medicine, ERJ Open Research, EMBO Molecular Medicine and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.